Francisco de Assis Acurcio (Franciscode Assis Acurcio, Francisco A de Assis Acurcio, Francisco A Acurcio, F A Acurcio, Francisco De Assis Acurcio, Francisco de Assis Acúrcio)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 25

Top Venues

Journal of comparative effectiveness research

Expert review of pharmacoeconomics & outcomes research

Expert review of clinical pharmacology

Expert review of clinical immunology

Universidade Federal de Minas Gerais

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade Federal de Minas Gerais Apr 03 1996

Brazil

Professor :: Social Pharmacy

Publications

Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, Adriana Maria Kakehasi, Alessandra Maciel Almeida, Pedro Ricardo Kömel Pimenta, Juliana Álvares Teodoro, Francisco de Assis Acurcio
First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study. Sao Paulo medical journal = Revista paulista de medicina 140 (6) (2022)
Elisa Neide Barbosa de Souza, Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, Edna Afonso Reis, Juliana Álvares Teodoro, Francisco de Assis Acurcio, Alessandra Maciel Almeida
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System. Einstein (Sao Paulo, Brazil) 20 (2022)
Pedro Ricardo Kömel Pimenta, Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, Adriana Maria Kakehasi, Francisco de Assis Acurcio, Juliana Álvares Teodoro
Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study. Journal of comparative effectiveness research 10 (6) (2021)
Francisco de Assis Acurcio, Augusto Afonso Guerra Junior, Maria Cristina Marino Calvo, Daniel Holthausen Nunes, Marco Akerman, Ligia Fonseca Spinel, Marina Morgado Garcia, Ramon Gonçalves Pereira, Igor da Costa Borysow, Rogério Renato Silva, Pâmela Santos Azevedo, Patrícia Caroline Iacabo Correia Gomes, Juliana Álvares Teodoro
Cost-minimization analysis of teledermatology versus conventional care in the Brazilian National Health System. Journal of comparative effectiveness research 10 (15) (2021)
Mariana M Barbosa, Thais A Moreira, Renata Cristina Rezende Macedo do Nascimento, Mariana Martins Gonzaga do Nascimento, Francisco de Assis Acurcio, Brian B Godman, Augusto Afonso Guerra Junior, Juliana Álvares Teodoro
Access to medicines in the Brazilian Unified Health System's primary health care: assessment of a public policy. Journal of comparative effectiveness research 10 (10) (2021)
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, Alessandra Maciel Almeida, Juliana Alvares-Teodoro, Francisco de Assis Acurcio
Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model. Expert review of pharmacoeconomics & outcomes research (2021)
Mariana M Barbosa, Renata Cristina Rezende Macedo do Nascimento, Marina M Garcia, Francisco de Assis Acurcio, Brian B Godman, Augusto Afonso Guerra Junior, Juliana Álvares Teodoro
Strategies to improve the availability of medicines in primary health care in Brazil: findings and implications. Journal of comparative effectiveness research 10 (3) (2021)
Wânia Cristina da Silva, Brian B Godman, Francisco de Assis Acurcio, Mariângela Leal Cherchiglia, Antony Paul Martin, Konrad Maruszczyk, Jans Bastos Izidoro, Marcos André Portella, Agner Pereira Lana, Orozimbo Henriques Campos Neto, Eli Iola Gurgel Andrade
The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil. Applied health economics and health policy 19 (4) (2021)
Wenderson Henrique Rocha, Juliana Álvares Teodoro, Francisco de Assis Acurcio, Augusto Afonso Guerra Junior, Isabel Cristina Gomes Moura, Brian B Godman, Amanj Baker Kurdi, Renata Cristina Rezende Macedo do Nascimento, Alessandra Maciel Almeida
Influence of pharmaceutical services organization on the availability of essential medicines in a public health system. Journal of comparative effectiveness research 10 (6) (2021)
Ana F Souza, Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, Alessandra Maciel Almeida, Francisco de Assis Acurcio, Juliana Álvares Teodoro
Medication adherence and persistence of psoriatic arthritis patients treated with biological therapy in a specialty pharmacy in Brazil: a prospective observational study. Pharmacy practice 19 (2) (2021)
Carolina Zampirolli Dias, Brian B Godman, Ludmila Peres Gargano, Pâmela Santos Azevedo, Marina Morgado Garcia, Maurílio de Souza Cazarim, Laís Lessa Neiva Pantuzza, Nelio Gomes Ribeiro-Junior, André Luiz Pereira, Marcus Carvalho Borin, Isabella de Figueiredo Zuppo, Roberto Iunes, Tomas Pippo, Renata Curi Hauegen, Carlos Vassalo, Tracey-Lea Laba, Steven R A Simoens, Sergio Márquez, Carolina Gomez, Luka Voncina, Gisbert W Selke, Livio Garattini, Hye-Young Kwon, Jolanta Gulbinovic, Aneta Lipinska, Maciej Pomorski, Lindsay McClure, Jurij Fürst, Rosana Gambogi, Carla Hernandez Ortiz, Vânia Cristina Canuto Santos, Denizar Vianna Araújo, Vânia Eloisa de Araújo, Francisco de Assis Acurcio, Juliana Álvares Teodoro, Augusto Afonso Guerra Junior
Integrative Review of Managed Entry Agreements: Chances and Limitations. PharmacoEconomics 38 (11) (2021)
Isabella Piassi Dias Godói, Túlio Tadeu Rocha Sarmento, Edna Afonso Reis, Ludmila Peres Gargano, Brian B Godman, Francisco de Assis Acurcio, Juliana Álvares Teodoro, Augusto Afonso Guerra Junior, Cristina Mariano Ruas
Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications. Expert review of pharmacoeconomics & outcomes research (2021)
Daniel Resende Faleiros, Juliana Álvares Teodoro, Everton Nunes da Silva, Brian B Godman, Ramon Gonçalves Pereira, Eli Iola Gurgel Andrade, Francisco de Assis Acurcio, Augusto Afonso Guerra Junior
Budget impact analysis of medicines: estimated values versus real-world evidence and the implications. Expert review of pharmacoeconomics & outcomes research (2021)
Francisco de Assis Acurcio, Augusto Afonso Guerra Junior, Michael Ruberson Ribeiro da Silva, Ramon Gonçalves Pereira, Brian B Godman, Marion Bennie, Hacene Nedjar, Elham Rahme
Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study. Current medical research and opinion 36 (4) (2020)
Haliton Alves de Oliveira Júnior, Tiago Pereira da Veiga, Francisco de Assis Acurcio, Alessandra Maciel Almeida, Jéssica Barreto Ribeiro Dos Santos, Michael Ruberson Ribeiro da Silva, Adriana Maria Kakehasi, Mariângela Leal Cherchiglia
Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff. Hospital practice (1995) 48 (4) (2020)
Thais A Moreira, J Alvares-Teodoro, M M Barbosa, R C R M Do Nascimento, Augusto Afonso Guerra Junior, Francisco de Assis Acurcio
Polypharmacy among adult and older adult users of primary care services delivered through the Unified Health System in Minas Gerais, Brazil. Expert review of clinical pharmacology 13 (12) (2020)
Wallace Breno Barbosa, Rosângela Maria Gomes, Brian B Godman, Francisco de Assis Acurcio, Augusto Afonso Guerra Junior
Real-world effectiveness of olanzapine and risperidone in the treatment of schizophrenia in Brazil over a 16-year follow-up period; findings and implications. Expert review of clinical pharmacology 14 (2) (2020)
Giovana Paula Rezende Simino, Ilka Afonso Reis, Francisco de Assis Acurcio, Eli Iola Gurgel Andrade, Natalia Maria Linhares Brazil, Mariângela Leal Cherchiglia
Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting. Revista de saude publica 54 (2020)
Jéssica Barreto Ribeiro Dos Santos, Michael Ruberson Ribeiro da Silva, Adriana Maria Kakehasi, Francisco de Assis Acurcio, Alessandra Maciel Almeida, Haliton Alves de Oliveira Júnior, Pedro Ricardo Kömel Pimenta, Juliana Alvares-Teodoro
FIRST LINE OF SUBCUTANEOUS ANTI-TNF THERAPY FOR RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT STUDY. Expert review of clinical immunology 16 (12) (2020)
Jéssica Barreto Ribeiro Dos Santos, Michael Ruberson Ribeiro da Silva, Alessandra Maciel Almeida, Francisco de Assis Acurcio, Juliana Álvares Teodoro
Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model. Expert review of pharmacoeconomics & outcomes research 21 (5) (2020)
Juliana de Oliveira Costa, Sallie-Anne Pearson, Francisco de Assis Acurcio, Palmira de Fátima Bonolo, Micheline Rosa Silveira, Maria das Graças Braga Ceccato
Health-related quality of life among HIV-infected patients initiating treatment in Brazil in the single-tablet regimen era. AIDS care 31 (5) (2019)
Jéssica Barreto Ribeiro Dos Santos, Augusto Afonso Guerra Junior, Michael Ruberson Ribeiro da Silva, Alessandra Maciel Almeida, Francisco de Assis Acurcio, Juliana Álvares Teodoro
First line of biological drugs in rheumatoid arthritis: a medication persistence analysis. Expert review of clinical pharmacology 12 (4) (2019)
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, Alessandra Maciel Almeida, Augusto Afonso Guerra Junior, Juliana Álvares Teodoro, Francisco de Assis Acurcio
Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations. Expert review of clinical immunology 15 (8) (2019)
Lívia Lovato Pires Lemos, Augusto Afonso Guerra Junior, Marisa da Silva Santos, Carlos Alberto da Silva Magliano, Isabela Diniz, Kathiaja Miranda Souza, Ramon Gonçalves Pereira, Juliana Álvares Teodoro, Brian Godman, Marion Bennie, Ivan Ricardo Zimmermann, Vânia Crisitna Canuto Dos Santos, Clarice Alegre Pretramale, Francisco de Assis Acurcio
The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil. PharmacoEconomics 36 (2) (2019)
Wânia Cristina da Silva, Vânia Eloisa de Araújo, Ellias Magalhães E Abreu Lima, Jéssica Barreto Ribeiro Dos Santos, Michael Ruberson Ribeiro da Silva, Paulo Henrique Ribeiro Fernandes Almeida, Francisco de Assis Acurcio, Brian B Godman, Amanj Baker Kurdi, Mariângela Leal Cherchiglia, Eli Iola Gurgel Andrade
Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 32 (6) (2019)

Francisco de Assis Acurcio.css-eqlu8i{font-size:small;padding-left:4px;} (Franciscode Assis Acurcio, Francisco A de Assis Acurcio, Francisco A Acurcio, F A Acurcio, Francisco De Assis Acurcio, Francisco de Assis Acúrcio)

Publication Activity (10 Years)

Top Topics

Top Venues

Francisco de Assis Acurcio (Franciscode Assis Acurcio, Francisco A de Assis Acurcio, Francisco A Acurcio, F A Acurcio, Francisco De Assis Acurcio, Francisco de Assis Acúrcio)